Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Demyelinating disorders
ADR ID BADD_A01193
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
Description Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS. [MeSH]
MedDRA Code 10012303
MeSH ID D003711
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Demyelinating Diseases | Demyelinating Disease | Demyelinating Disorders | Demyelinating Disorder | Demyelination | Demyelinations | Clinically Isolated Syndrome, CNS Demyelinating | Clinically Isolated CNS Demyelinating Syndrome
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D01083Hydrochlorothiazide
BADD_D01086Hydrocortisone
BADD_D01103Hydroxychloroquine
BADD_D01119Ibrutinib
BADD_D01130Idelalisib
BADD_D01133Ifosfamide
BADD_D01136Imatinib
BADD_D01142Imiquimod
BADD_D01149Indapamide
BADD_D01204Isoniazid
BADD_D01242Lamivudine
BADD_D01253Lenalidomide
BADD_D01265Levetiracetam
BADD_D01275Levofloxacin
BADD_D01281Levonorgestrel
BADD_D01285Levothyroxine
BADD_D01300Lisinopril
BADD_D01352Maraviroc
BADD_D01366Medroxyprogesterone acetate
BADD_D01401Metformin
BADD_D01418Methotrexate
BADD_D01435Methylprednisolone hemisuccinate
BADD_D01445Metoprolol
BADD_D01449Metronidazole
BADD_D01465Miglustat
BADD_D01476Mirtazapine
BADD_D01480Mitoxantrone
BADD_D01484Modafinil
BADD_D01496Montelukast
BADD_D01507Mycophenolate mofetil
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages